Objective: Dietary supplementation with guar gum or fructose has been reported to reduce the postprandial glycemic response to an oral glucose challenge. As a result of the poor palatability of most foods containing guar gum, a novel low-viscosity beverage with guar gum was developed that becomes viscous in vivo through an enzymatic induction. The primary study objective was to determine the effect of an amylase-induced viscosity (I-V) product, with or without supplemental fructose, on the postprandial glycemic response to a high glycemic index test meal in healthy nondiabetic subjects. Design: The study was a four-treatment, placebo-controlled, double-blind, randomized block protocol. Setting: The study was performed at Glycaemic Index Testing, Inc., Toronto, Ontario, Canada. Subjects: A total of 30 healthy nondiabetic volunteers (13 male, 17 female, mean7s.e.m. age of 5173 y and body mass index of 24.270.4 kg/m 2 ) participated in the study. Intervention: In the morning after an overnight fast, subjects participated in four 3-h meal glucose tolerance tests on separate occasions. The test meals contained 50 g of available carbohydrate from maltodextrin and white bread (control) or the same meal with either 5 g of guar gum (3.6 g galactomannan), 5 g of fructose, or 5 g of guar gum þ 5 g of fructose.Results: Treatments containing guar gum had a reduced (Po0.01) baseline-adjusted peak glucose response and incremental area under the glucose curve. In contrast to previous studies, fructose increased (Po0.05) the baseline-adjusted peak glucose concentration. Conclusions: Guar gum incorporated into an amylase I-V product provided a means to stabilize blood glucose levels by reducing the early phase excursion and then by appropriately maintaining the later phase excursion in healthy nondiabetic humans.